Sort
39,280 grants matching “leukemia”
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
$538,000Jennifer Jean Trowbridge · Jackson Laboratory · U01 · FY2021 · AG
Humanized bone marrow-like model to study patient-derived myeloma xenografts
$537,912Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2018 · CA
MYB family alterations in pediatric gliomas
$537,868Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Spermatogonial Stem Cell Self-Renewal and Differentiation
$537,794Robert E Braun · University Of Washington · U54 · FY2010 · HD
Biodefense Project
$537,787Steven Simon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
System dynamics and gene network architecture of early T-cell development
$537,755Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2023 · HD
System dynamics and gene network architecture of early T-cell development
$537,755Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2022 · HD
System dynamics and gene network architecture of early T-cell development
$537,755Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2021 · HD
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
$537,748Margaret Goodell · Baylor College Of Medicine · R01 · FY2016 · CA
Targeting DNA repair to eradicate TKI-refractory/resistant CML
$537,724Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2014 · CA
NextGen - CHOP
$537,702John M Maris · Children'S Hosp Of Philadelphia · OT2 · FY2023 · CA
THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND
$537,580Sloan-Kettering Institute For Cancer Res · U01 · FY2003 · CA
Parental genotypes and exposures in sporadic retinoblastoma
$537,579Arupa Ganguly · University Of Pennsylvania · R01 · FY2011 · CA
MATH INTERVENTION FOR CHILDREN WITH LEUKEMIA
$537,575University Of Arizona · R01 · FY2004 · NR
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
$537,558Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Mitochondrial Dysfunction Underlies the Integrated Stress Response Activation in Ponatinib-Induced Cardiotoxicity
$537,250Won Hee Lee · University Of Arizona · R01 · FY2025 · HL
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
$537,057Nicola J Camp · University Of Utah · R01 · FY2011 · CA
The cohesin complex as a tumor suppressor in myeloid leukemia
$536,993Iannis Aifantis · New York University School Of Medicine · R01 · FY2017 · CA
Tumor Microenvironment in Cancer Progression
$536,966Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
$536,959Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2013 · CA
Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies
$536,949Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2023 · CA
Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies
$536,949Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2022 · CA
Pooling and expansion of Chronic Lymphocytic Leukemia GWA data
$536,926Susan L Slager · Mayo Clinic Rochester · R01 · FY2012 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$536,912Philip D Greenberg · University Of Washington · R01 · FY2015 · CA
Inflammation as determinant of clonal selection in MPN progression
$536,869Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2019 · HL